Zenyatta Ventures Ltd. is a Mineral Exploration and Development Company based in Thunder Bay, Ontario. Zenyatta is currently developing the Albany Graphite Deposit a rare, igneous related, hydrothermal graphite deposit with the potential to produce a natural, high purity graphite that may compete in high technology markets traditionally reserved for synthetic graphite. To date, Albany is the largest and only known global deposit within the rare igneous hosted, hydrothermal subclass of graphite deposits to be in development.
Quote | ZEN Graphene Solutions Ltd (OTCMKTS:ZENYF)
Last: | $2.84 |
---|---|
Change Percent: | 10.94% |
Open: | $2.6524 |
Close: | $2.84 |
High: | $2.84 |
Low: | $2.6 |
Volume: | 38,888 |
Last Trade Date Time: | 03/21/2022 04:54:05 pm |
News | ZEN Graphene Solutions Ltd (OTCMKTS:ZENYF)
GUELPH, ON / ACCESSWIRE / April 3, 2024 / Zentek Ltd. (" Zentek " or the " Company ") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company, is pleased to announce that it has entered into a definitive distribution agreement with Dallas, Texas-based Medwell...
GUELPH, ON / ACCESSWIRE / March 25, 2024 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN) , announces that its wholly-owned subsidiary Triera Biosciences Ltd. ("Triera") has completed testing demonstrating that its C19HBA SARS-CoV-2 universal aptamer built on the proprietary hig...
Message Board Posts | ZEN Graphene Solutions Ltd (OTCMKTS:ZENYF)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
ZEN Graphene Solutions Ltd Company Name:
ZENYF Stock Symbol:
OTCMKTS Market:
GUELPH, ON / ACCESSWIRE / April 3, 2024 / Zentek Ltd. (" Zentek " or the " Company ") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company, is pleased to announce that it has entered into a definitive distribution agreement with Dallas, Texas-based Medwell...
GUELPH, ON / ACCESSWIRE / March 25, 2024 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN) , announces that its wholly-owned subsidiary Triera Biosciences Ltd. ("Triera") has completed testing demonstrating that its C19HBA SARS-CoV-2 universal aptamer built on the proprietary hig...
GUELPH, ON / ACCESSWIRE / January 30, 2024 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN) announces that its wholly-owned subsidiary Triera Biosciences Ltd. ("Triera")has completed testing of its C19HBA aptamer as a potential therapeutic. The SARS-CoV-2 universal aptamer buil...